Skip to main content
Erschienen in: Rheumatology International 1/2013

01.01.2013 | Original Article

Assessment of sexual functions in female patients with ankylosing spondylitis compared with healthy controls

verfasst von: Saliha Eroglu Demir, Aylin Rezvani, Seniz Ok

Erschienen in: Rheumatology International | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Healthy human sexuality is integral to a well-lived life. Recent studies reported that sexual problems were common in patients with ankylosing spondylitis (AS) in relation to the consequences of the illness such as pain, stiffness of the spine and depression. Twenty-three female patients with AS and 27 healthy female controls were applied the Female Sexual Function Index (FSFI) to determine the influence of the disease on sexual functions. The rate of low sexual function was 60.9% in female patients with AS and 66.7% in healthy controls (P > 0.05). Ten patients were depressed in our study group according to the Beck Depression Inventory (BDI), while 15 healthy controls were depressed (P > 0.05). No statistically significant differences were found between the female patients and controls in FSFI and BDI scores. There was a significant correlation between BDI and total FSFI, desire and orgasm domains in female patients with AS. Pain, disease activity and functional status of the patients with AS were correlated with FSFI. However, there was no correlation between spinal mobility, laboratory parameters and sexual functions. General health, vitality, emotional role and mental health subscales of Short Form-36 were correlated with total FSFI scores. We did not find any relationship between AS quality of life scale and sexual functions. Sexual dysfunctions are common, but not different in female patients with AS when compared with healthy controls. Sexual problems in female patients with AS seem to be associated with higher depression level, increased disease activity, decreased functionality, higher pain scores and decreased quality of life.
Literatur
1.
Zurück zum Zitat Tristano AG (2009) The impact of rheumatic diseases on sexual function. Rheumatol Int 29:853–860CrossRefPubMed Tristano AG (2009) The impact of rheumatic diseases on sexual function. Rheumatol Int 29:853–860CrossRefPubMed
2.
Zurück zum Zitat Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K, Ugur M, Kaya A, Gur A, Erdal A, Ardicoglu O, Tekeoglu I, Cevik R, Yildirim K, Kamanli A, Sarac AJ, Karatay S, Ozgocmen S (2011) Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int 31:795–800CrossRefPubMed Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K, Ugur M, Kaya A, Gur A, Erdal A, Ardicoglu O, Tekeoglu I, Cevik R, Yildirim K, Kamanli A, Sarac AJ, Karatay S, Ozgocmen S (2011) Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int 31:795–800CrossRefPubMed
3.
Zurück zum Zitat Domone C (2009) Sexual function in women: what is normal? Int Urogynecol J 20:9–17CrossRef Domone C (2009) Sexual function in women: what is normal? Int Urogynecol J 20:9–17CrossRef
5.
Zurück zum Zitat Cakar E, Dincer U, Kiralp MZ, Taskaynatan MA, Yasar E, Bayman EO, Ozgul A, Dursun H (2007) Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. Clin Rheumatol 26:1607–1613CrossRefPubMed Cakar E, Dincer U, Kiralp MZ, Taskaynatan MA, Yasar E, Bayman EO, Ozgul A, Dursun H (2007) Sexual problems in male ankylosing spondylitis patients: relationship with functionality, disease activity, quality of life, and emotional status. Clin Rheumatol 26:1607–1613CrossRefPubMed
6.
Zurück zum Zitat Pirildar T, Muezzinoglu T, Pirildar S (2004) Sexual function in ankylosing spondylitis: a study of 65 men. J Urol 171:1598–1600CrossRefPubMed Pirildar T, Muezzinoglu T, Pirildar S (2004) Sexual function in ankylosing spondylitis: a study of 65 men. J Urol 171:1598–1600CrossRefPubMed
7.
Zurück zum Zitat Dincer U, Cakar E, Kiralp MZ, Dursun H (2007) Assessment of sexual dysfunction in male patients with Ankylosing Spondylitis. Rheumatol Int 27:561–566CrossRefPubMed Dincer U, Cakar E, Kiralp MZ, Dursun H (2007) Assessment of sexual dysfunction in male patients with Ankylosing Spondylitis. Rheumatol Int 27:561–566CrossRefPubMed
8.
Zurück zum Zitat Lee W, Reveille J, Davis JJ, Learch T, Ward M, Weisman M (2007) Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 66:633–638CrossRefPubMed Lee W, Reveille J, Davis JJ, Learch T, Ward M, Weisman M (2007) Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 66:633–638CrossRefPubMed
9.
Zurück zum Zitat Kingsberg S, Althof S (2009) Evaluation and treatment of female sexual disorders. Int Urogynecol J Pelvic Floor Dysfunct 20:33–34 Kingsberg S, Althof S (2009) Evaluation and treatment of female sexual disorders. Int Urogynecol J Pelvic Floor Dysfunct 20:33–34
10.
Zurück zum Zitat Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’agostino RJ (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208CrossRefPubMed Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’agostino RJ (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208CrossRefPubMed
11.
Zurück zum Zitat van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefPubMed
12.
Zurück zum Zitat Verit F, Verit A, Billurcu A (2009) Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression. Maturitas 64:38–42CrossRefPubMed Verit F, Verit A, Billurcu A (2009) Low sexual function and its associated risk factors in pre- and postmenopausal women without clinically significant depression. Maturitas 64:38–42CrossRefPubMed
13.
Zurück zum Zitat Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1–20CrossRefPubMed Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1–20CrossRefPubMed
14.
Zurück zum Zitat Oksuz E, Malhan S (2006) Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 175:654–658CrossRefPubMed Oksuz E, Malhan S (2006) Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 175:654–658CrossRefPubMed
15.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
16.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed
17.
Zurück zum Zitat Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25:280–284CrossRefPubMed Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25:280–284CrossRefPubMed
18.
Zurück zum Zitat Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285PubMed
19.
Zurück zum Zitat Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N (2005) The Turkish versions of the bath ankylosing spondylitis and dougados functional indices: reliability and validity. Rheumatol Int 25:612–618CrossRefPubMed Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N (2005) The Turkish versions of the bath ankylosing spondylitis and dougados functional indices: reliability and validity. Rheumatol Int 25:612–618CrossRefPubMed
20.
Zurück zum Zitat Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21:1694–1698PubMed Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21:1694–1698PubMed
21.
Zurück zum Zitat Ware JJ, Sherbourne C (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMed Ware JJ, Sherbourne C (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMed
22.
Zurück zum Zitat Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA (2003) Development of ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26CrossRefPubMed Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA (2003) Development of ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26CrossRefPubMed
23.
Zurück zum Zitat Demirsoy AC (1999) The MOS SF-36 health survey: a validation study with a Turkish sample. Thesis, Bogazici University, Istanbul Demirsoy AC (1999) The MOS SF-36 health survey: a validation study with a Turkish sample. Thesis, Bogazici University, Istanbul
24.
Zurück zum Zitat Duruoz T, Doward L, Cerrahoglu L, Turan Y, Yurtkuran M, Calis M et al. (2007) Validity and reliability of the Turkish version of the ankylosing spondylitis quality of life (ASQoL) scale. In: Proceedings of the 21th congress of national physical medicine and rehabilitation, Antalya, Turkey, p 50 Duruoz T, Doward L, Cerrahoglu L, Turan Y, Yurtkuran M, Calis M et al. (2007) Validity and reliability of the Turkish version of the ankylosing spondylitis quality of life (ASQoL) scale. In: Proceedings of the 21th congress of national physical medicine and rehabilitation, Antalya, Turkey, p 50
25.
Zurück zum Zitat Rkain H, Allali F, Bentalha A, Lazrak N, Abouqal R, Hajjaj-Hassouni N (2007) Socioeconomic impact of ankylosing spondylitis in Morocco. Clin Rheumatol 26:2081–2088CrossRefPubMed Rkain H, Allali F, Bentalha A, Lazrak N, Abouqal R, Hajjaj-Hassouni N (2007) Socioeconomic impact of ankylosing spondylitis in Morocco. Clin Rheumatol 26:2081–2088CrossRefPubMed
26.
Zurück zum Zitat Bal S, Bal K, Turan Y, Deniz G, Gurgan A, Berkit IK, Sendur OF (2011) Sexual functions in ankylosing spondylitis. Rheumatol Int 31:889–894CrossRefPubMed Bal S, Bal K, Turan Y, Deniz G, Gurgan A, Berkit IK, Sendur OF (2011) Sexual functions in ankylosing spondylitis. Rheumatol Int 31:889–894CrossRefPubMed
27.
Zurück zum Zitat Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dincer K, Kalyon TA (2006) Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168–174CrossRefPubMed Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dincer K, Kalyon TA (2006) Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168–174CrossRefPubMed
28.
Zurück zum Zitat Akkus Y, Nakas D, Kalyoncu U (2010) Factors affecting the sexual satisfaction of patients with rheumatoid arthritis and ankylosing spondylitis. Sex Disabil 28:223–232CrossRef Akkus Y, Nakas D, Kalyoncu U (2010) Factors affecting the sexual satisfaction of patients with rheumatoid arthritis and ankylosing spondylitis. Sex Disabil 28:223–232CrossRef
29.
Zurück zum Zitat Baraliakos X, Listing J, von der Recke A, Braun J (2011) The natural course of radiographic progression in ankylosing spondylitis: differences between genders and appearance of characteristic radiographic features. Curr Rheumatol Rep 13:383–387CrossRefPubMed Baraliakos X, Listing J, von der Recke A, Braun J (2011) The natural course of radiographic progression in ankylosing spondylitis: differences between genders and appearance of characteristic radiographic features. Curr Rheumatol Rep 13:383–387CrossRefPubMed
30.
Zurück zum Zitat Healey EL, Haywood KL, Jordan KP, Garratt AM, Ryan S, Packham JC (2009) Ankylosing spondylitis and its impact on sexual relationships. Rheumatology (Oxford) 48:1378–1381CrossRef Healey EL, Haywood KL, Jordan KP, Garratt AM, Ryan S, Packham JC (2009) Ankylosing spondylitis and its impact on sexual relationships. Rheumatology (Oxford) 48:1378–1381CrossRef
31.
Zurück zum Zitat Basson R (2005) Women’s sexual dysfunction: revised and expanded definitions. CMAJ 172:1327–1333CrossRefPubMed Basson R (2005) Women’s sexual dysfunction: revised and expanded definitions. CMAJ 172:1327–1333CrossRefPubMed
32.
Zurück zum Zitat Berman JR (2005) Physiology of female sexual function and dysfunction. Int J Impot Res 17:44–51CrossRef Berman JR (2005) Physiology of female sexual function and dysfunction. Int J Impot Res 17:44–51CrossRef
33.
Zurück zum Zitat Davis SR, Jane F (2011) Sex and perimenopause. Aust Fam Physician 40:274–278PubMed Davis SR, Jane F (2011) Sex and perimenopause. Aust Fam Physician 40:274–278PubMed
Metadaten
Titel
Assessment of sexual functions in female patients with ankylosing spondylitis compared with healthy controls
verfasst von
Saliha Eroglu Demir
Aylin Rezvani
Seniz Ok
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 1/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2340-x

Weitere Artikel der Ausgabe 1/2013

Rheumatology International 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.